AARTI DRUGS LTD
AARTIDRUGS.NS
₹ 348.65
5%
Aarti Drugs Ltd
Aarti Drugs Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Aarti Drugs is ₹ 348.65 that is ₹ 16.55 -4.53% with respect to the previous day’s close price. The stock price of Aarti Drugs was last updated 8 hours ago.
Aarti Drugs Stock Price Performance
In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.
Aarti Drugs Live Share Price Analysis
AARTI DRUGS LTD
₹ 348.65
Open ₹ 365.20
High ₹ 378.80
Marketcap 32.31B
Close ₹ 348.65
Low ₹ 341.00
Volume ₹ 1,267,710.00
The stock of Aarti Drugs Ltd strated the trade at an Open price of ₹ 365.20 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 378.80 and an Intraday Low price of ₹ 341.00%. As per last updated 8 hours ago, the Shares of Aarti Drugs were trading at a price of ₹ 348.65 which is ₹ 16.55 -4.53% as compared the price ₹ 365.20 at which the stock close on the previous trading day. The total traded volume for the day stood at 1,267,710 number of shares.
Candlestick Chart of Aarti Drugs Share Price Movements
The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).
Historical Performance of Aarti Drugs Shares
| 52 Week Range | Price | 52 Weeks Low | 52 Weeks High |
|---|---|---|---|
| ₹ 348.65 | ₹ 313.90 | ₹ 531.40 |
Here is Aarti Drugs’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 531.40. On the lower side, the stock has been to the 52 weeks low price level of ₹ 313.90. It’s last traded price was ₹ 348.65 as on last update 8 hours ago. The one-year line chart clearly shows how the price of Aarti Drugs’s stock has moved in the last twelve months.
The Company has posted an earnings of ₹ 17.31 per share (EPS TTM) in the trailing twelve months period. Aarti Drugs’s last annual dividend rate was 1%, which translates to a 0.27382255% of annual dividend yield.
Line Chart of Aarti Drugs Stock Price
Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.
Companies Similar to Aarti Drugs
Aarti Drugs Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Aarti Drugs are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.
Share Price Snapshot Companies Similar to Aarti Drugs
Select list of companies is given below. To view more about the Industry and see other companies from Pharmaceuticals & Drugs Industry, click on the industry name.
About Aarti Drugs
Aarti Drugs Ltd is a Aarti Group Company. The company operates in the Pharmaceuticals & Drugs sector. It is a pharmaceutical company. Incorporated in 1984, it has around 37 years of operations. Aarti Drugs live share price is ₹ 348.65. It is a Small Cap stock and had a market capitalization of ₹ 32,307,093,504.00 as on 8 hours ago.
- Aarti Drugs offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.
- Its products under APIs include Aceclofenac, Diclofenac Potassium, Diclofenac Diethylamine, Clopidogrel Bisulphate and Telmisartan.
- Its pharma intermediates include Antiprotozoal, Celecoxib, Antibiotic, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Zolpidem and Telmisartan.
- It also offers specialty chemicals, such as Benzene Sulphonamide, Benzene Sulphonic acid methyl ester, Benzene Sulphonyl chloride, Methyl Nicotinate, N-Methyl Methane Sulphonamide, Ortho para toluene Sulphonamide, Ortho/para toluene Sulphonic acid methyl ester, Para chloro benzene sulphonamide, Para Toluene Sulphonic acid methyl ester and Para Toluene Sulphonyl Chloride. Pinnacle Life Science Private Limited is the subsidiary of the Company.
The registered office of Aarti Drugs is located in Thane, Maharashtra. The registrar and share transfer agent for Aarti Drugs is Link Intime India Pvt Ltd. The Stock Exchanges on which shares of Aarti Drugs Ltd is listed includes BSE, NSE.
AARTI DRUGS LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Employees: 1450
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol C, bisphenol C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.
| Address | Mahendra Industrial Estate, Mumbai, India |
| Country | India |
| Phone | 91 22 2401 9025 |
| Website | https://www.aartidrugs.co.in |
Aarti Drugs Recent News
No Recent News found for Aarti Drugs Ltd.